Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis
Advanced Science · 2026-10 · 13 (56)
DOI: 10.1002/advs.76585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.07.2026. Verfasst von Ayushi Mairal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, India. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Probiotics, Intestinal Mucosa, Extracellular Vesicles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research Board (SERB), Indian Council of Medical Research (ICMR).
Abstract (Originalsprache)
Ulcerative colitis remains challenging to treat due to the need for localized control of inflammation, restoration of mucosal integrity, and avoidance of systemic toxicity. Here, we report a rectally administered, sprayable, thermo‐responsive hyaluronic acid‐based copolymer platform for the localized co‐delivery of probiotic‐derived extracellular vesicles (ProEVs) and 5‐aminosalicylic acid. This system enables enhanced retention and sustained presentation of therapeutics at inflamed colonic sites. The combined formulation demonstrates improved therapeutic efficacy compared to individual treatments, promoting mucosal recovery and intestinal homeostasis. Mechanistically, the platform modulates inflammatory responses, supports epithelial barrier function, and contributes to microbiota rebalancing. Notably, extracellular vesicles provide a more effective and consistent therapeutic modality compared to live probiotics. Importantly, the formulation is designed for clinical translation, offering localized administration, minimal toxicity, and stability upon lyophilization, enabling off‐the‐shelf use. These findings highlight the potential of integrating extracellular vesicles with biomaterial‐based delivery systems as a multifunctional therapeutic strategy for inflammatory bowel disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur, UP, India.
- Centre For Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur, UP, India.
- The Mehta Family Centre For Engineering in Medicine, Indian Institute of Technology Kanpur, Kanpur, UP, India.
- Department of Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden.
- Centre of Excellence for Materials in Medicine, Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, UP, India.
- Centre For Nanosciences, Indian Institute of Technology Kanpur, Kanpur, UP, India.
ORCID-Profile: Saravanan Matheshwaran
Förderung
- Science and Engineering Research Board (SERB)
- Indian Council of Medical Research (ICMR)
Zitieren
APA
Mairal, A., Tariq, U., Mehrotra, S., Matheshwaran, S., Marsal, J., & Kumar, A. (2026). Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis. Advanced Science, 13(56). https://doi.org/10.1002/advs.76585
Vancouver
Mairal A, Tariq U, Mehrotra S, Matheshwaran S, Marsal J, Kumar A. Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis. Advanced Science. 2026;13(56). doi:10.1002/advs.76585
BibTeX
@article{Mairal2026,
author = {Mairal, Ayushi and Tariq, Ubaid and Mehrotra, Shreya and Matheshwaran, Saravanan and Marsal, Jan and Kumar, Ashok},
title = {Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {56},
doi = {10.1002/advs.76585}
}
EUVIMED